p.87 抽出テキスト

1991; 14: 83-86. PMID: 1839810 181. Kato M, Adachi T, Koshino Y, et al. Obstructive sleep apnea and cardiovascular disease. Circ J 2009; 73: 1363- 1370. PMID: 19564701 182. Drager LF, Togeiro SM, Polotsky VY, et al. Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol 2 0 1 3 ; 6 2 : 5 6 9 - 5 7 6 . PMID: 23770180 183. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-2464. PMID: 12034649 184. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of Creactive protein and interleukin- 6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129- 1134. PMID: 12615790 185. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-1316. PMID: 9141509 186. Bozic J, Borovac JA, Galic T, et al. Adropin and Inflammation Biomarker Levels in Male Patients With Obstructive Sleep Apnea: A Link With Glucose Metabolism and Sleep Parameters. J Clin Sleep Med 2018; 14: 1109-1118. PMID: 29991422 187. Kasai T, Inoue K, Kumagai T, et al. Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea. Am J Hypertens 2011; 24: 401-407. PMID: 21193850 188. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112: 2660-2667. PMID: 16246965 189. Cahan C, Decker MJ, Arnold JL, et al. Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients. J Appl Physiol (1985) 1992; 72: 2112-2117. PMID: 1629063 190. Winnicki M, Shamsuzzaman A, Lanfranchi P, et al. Erythropoietin and obstructive sleep apnea. Am J Hypertens 2004; 17: 783-786. PMID: 15363820 191. Imagawa S, Yamaguchi Y, Higuchi M, et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea--hypopnea syndrome. Blood 2001; 98: 1255- 1257. PMID: 11493479 192. Guo Q, Wang Y, Li QY, et al. Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept. Sleep Breath 2013; 17: 311-316. PMID: 22437910 193. Cofta S, Wysocka E, Piorunek T, et al. Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. J Physiol Pharmacol 2008; 59 Suppl: 183-190. PMID: 19218642 194. Mancuso M, Bonanni E, LoGerfo A, et al. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med 2012; 13: 632-636. PMID: 22534161 195. Takahashi K, Chin K, Nakamura H, et al. Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox Signal 2008; 10: 715-726. PMID: 18199002 196. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610. PMID: 11085964 197. Ohike Y, Kozaki K, Iijima K, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure: Possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005; 69: 221-226. PMID: 15671617 198. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008; 117: 2270-2278. PMID: 18413499 199. Bayram NA, Ciftci B, Keles T, et al. Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep 2009; 32: 1257-1263. PMID: 19848355 200. Azuma M, Chihara Y, Yoshimura C, et al. Association between endothelial function (assessed on reactive hyperemia peripheral arterial tonometry) and obstructive sleep apnea, visceral fat accumulation, and serum adiponectin. Circ J 2015; 79: 1381- 1389. PMID: 25808226 201. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677- 682. PMID: 11874813 202. Pamidi S, Wroblewski K, Broussard J, et al. Obstructive sleep apnea in young lean men: Impact on insulin sensitivity and secretion. Diabetes Care 2012; 35: 2384-2389. PMID: 22912423 203. Lindberg E, Theorell-Haglöw J, Svensson M, et al. Sleep apnea and glucose metabolism: A long-term follow-up in a communitybased sample. Chest 2012; 142: 935-942. PMID: 22499826 204. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol (1985) 2009; 106: 1538-1544. PMID: 19265062 205. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435- 1439. PMID: 10543671 206. Broussard JL, Ehrmann DA, Van Cauter E, et al. Impaired insulin signaling in human adipocytes after experimental sleep restriction: A randomized, crossover study. Ann Intern Med 2012; 157: 549-557. PMID: 23070488 207. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010; 137: 95-101. PMID: 19542260 208. Prabhakar NR, Peng YJ, Nanduri J. Hypoxia-inducible factors and obstructive sleep apnea. J Clin Invest 2020; 130: 5042- 5051. PMID: 32730232 209. Newhouse LP, Joyner MJ, Curry TB, et al. Three hours of intermittent hypoxia increases circulating glucose levels in healthy adults. Physiol Rep 2017; 5: e13106. PMID: 28087818 210. Tasali E, Leproult R, Ehrmann DA, et al. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 2008; 105: 1044-1049. PMID: 18172212 211. Herzog N, Jauch-Chara K, Hyzy F, et al. Selective slow wave sleep but not rapid eye movement sleep suppression impairs morning glucose tolerance in healthy men. Psychoneuroendocrinology 2013; 38: 2075-2082. PMID: 23602132 212. Pamidi S, Wroblewski K, Stepien M, et al. Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial. Am J Respir Crit Care Med 2015; 192: 96-105. PMID: 25897569 213. Martínez-Cerón E, Barquiel B, Bezos AM, et al. Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial. Am J Respir Crit Care Med 2016; 194: 476- 485. PMID: 26910598 214. Kritikou I, Basta M, Vgontzas AN, et al. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Respir J 2014; 43: 145-155. PMID: 23598957 215. Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 2014; 370: 2265- 2275. PMID: 24918371 216. Abud R, Salgueiro M, Drake L, et al. Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: a systematic review and meta-analysis. Sleep Med 2019; 62: 14-21. PMID: 31518943 217. Shang W, Zhang Y, Wang G, et al. Benefits of continuous positive airway pressure on glycaemic control and insulin resistance in patients with type 2 diabetes and obstructive sleep apnoea: A meta-analysis. Diabetes Obes Metab 2021; 23: 540-548. PMID: 33146450 218. Harsch IA, Schahin SP, Radespiel-Tröger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156-162. PMID: 14512265 219. Harsch IA, Schahin SP, Brückner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004; 71: 252-259. PMID: 15133345 220. Linz D, Woehrle H, Bitter T, et al. The importance of sleepdisordered breathing in cardiovascular disease. Clin Res Cardiol 2015; 104: 705-718. PMID: 25903111 221. Chou KT, Huang CC, Chen YM, et al. Sleep apnea and risk of deep vein thrombosis: a non-randomized, pair-matched cohort study. Am J Med 2012; 125: 374-380. PMID: 22444103 222. Toraldo DM, De Benedetto M, Scoditti E, et al. Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure. Sleep Breath 2016; 20: 457- 465. PMID: 26169715 223. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939. PMID: 11934717